Clinical Trial Update: [18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing [18F]Fluoroestradiol-PET/CT imaging for invasive lobular breast carcinoma; the study was terminated but results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Lobular Breast Carcinoma

Drugs mentioned

• [18F]Fluoroestradiol (fluoroestradiol (18F))

Snippet

Sponsor: University of Utah | Conditions: Invasive Lobular Breast Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-05-18